Canafax DM - Search Results

1

Effects of ketoconazole on cyclosporine metabolism in renal allograft recipients.

Sorenson AL, Lovdahl M, Hewitt JM, Granger DK, Almond PS, Russlie HQ, Barber D, Matas AJ, Canafax DM. Sorenson AL, et al. Among authors: canafax dm. Transplant Proc. 1994 Oct;26(5):2822. Transplant Proc. 1994. PMID: 7940888 Clinical Trial. No abstract available.

2

Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients.

Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DE, Najarian JS. Frey DJ, et al. Transplantation. 1992 Jul;54(1):50-6. doi: 10.1097/00007890-199207000-00008. Transplantation. 1992. PMID: 1631944 Clinical Trial.

3

An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone.

Wrenshall LE, Matas AJ, Canafax DM, Min DI, Sibley RJ, Dunn DL, Payne WD, Sutherland DE, Najarian JS. Wrenshall LE, et al. Among authors: canafax dm. Transplantation. 1990 Aug;50(2):233-7. doi: 10.1097/00007890-199008000-00012. Transplantation. 1990. PMID: 2382291

4

Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy.

Granger DK, Cromwell JW, Chen SC, Goswitz JJ, Morrow DT, Beierle FA, Sehgal SN, Canafax DM, Matas AJ. Granger DK, et al. Among authors: canafax dm. Transplantation. 1995 Jan 27;59(2):183-6. Transplantation. 1995. PMID: 7839438

5

Cyclosporine levels impact early rejection episodes.

Granger DK, Amin NB, Sorenson AL, Gillingham KJ, Canafax DM, Matas AJ. Granger DK, et al. Among authors: canafax dm. Transplant Proc. 1994 Oct;26(5):2513. Transplant Proc. 1994. PMID: 7940771 No abstract available.

6

Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy.

Canafax DM, Carleton BC, Matas AJ, Payne WD, Dunn DL, Sutherland DE, Najarian JS. Canafax DM, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1692-3. Transplant Proc. 1993. PMID: 8442239 No abstract available.

7

Do early cyclosporine levels affect the incidence of acute rejection in renal transplant recipients?

Johnson EM, Canafax DM, Gillingham K, Schmidt W, Pandian K, Najarian JS, Matas AJ. Johnson EM, et al. Among authors: canafax dm. Transplant Proc. 1996 Apr;28(2):879. Transplant Proc. 1996. PMID: 8623444 No abstract available.

8

Combined rapamycin and cyclosporine immunosuppression in a porcine renal transplant model.

Granger DK, Cromwell JW, Canafax DM, Matas AJ. Granger DK, et al. Among authors: canafax dm. Transplant Proc. 1996 Apr;28(2):984. Transplant Proc. 1996. PMID: 8623488 No abstract available.

9

A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.

Johnson EM, Zimmerman J, Duderstadt K, Chambers J, Sorenson AL, Granger DK, Almond PS, Fryer Jp, Leventhal JR, Scarola J, Matas AJ, Canafax DM. Johnson EM, et al. Among authors: canafax dm. Transplant Proc. 1996 Apr;28(2):987. Transplant Proc. 1996. PMID: 8623490 Clinical Trial. No abstract available.

10

Effect of early cyclosporine levels on kidney allograft rejection.

Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ. Johnson EM, et al. Among authors: canafax dm. Clin Transplant. 1997 Dec;11(6):552-7. Clin Transplant. 1997. PMID: 9408683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters